Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimum safety requirements for preclinical testing

F Dorner1, P N Barrett, H P Schwartz

  • 1Biomedical Research Center, Immuno AG, Orth, Austria.

Developments in Biological Standardization
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Prehospital Pain Management on Emergency Department Management of Injured Children.

Prehospital emergency care·2021
Same author

Foreword.

Lipids·2016
Same author

Tick-borne encephalitis vaccines.

Internal medicine journal·2013
Same author

Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
Same author

About the Effect of Phenols on Diphtheria Toxin Toxoid and Antitoxin.

Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin·2010
Same author

Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms.

Leukemia·2010
Same journal

International challenges and public policy issues.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in China.

Developments in biological standardization·2000
Same journal

ICH activities on biotech topics.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in the European Union.

Developments in biological standardization·2000
Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000
Same journal

Control of foot-and-mouth disease by vaccination.

Developments in biological standardization·2000
See all related articles

Novel biotechnology produces diverse medicinal biological products, including proteins, antibodies, and vaccines. Safety testing is crucial due to complex product characteristics and manufacturing processes.

Area of Science:

  • Biotechnology and Biopharmaceuticals
  • Drug Development and Safety Evaluation

Background:

  • Novel biotechnology processes enable the production of a wide array of biological products for medicinal applications.
  • These products encompass human proteins, peptides, hormones, cytokines, blood products, monoclonal antibodies, and vaccine antigens.

Purpose of the Study:

  • To describe the safety testing required for novel biological products manufactured through biotechnology.
  • To address potential safety concerns associated with the manufacturing processes and product complexity.

Main Methods:

  • Overview of acute and repeated dose toxicity testing protocols.
  • Description of pharmacodynamic and immunological testing methodologies.
  • Discussion of essential product-specific biochemical and safety tests.

Related Experiment Videos

Main Results:

  • Biotechnology offers diverse therapeutic and prophylactic biological agents.
  • Comprehensive safety evaluations are indispensable for these complex products.
  • Standardized and specific testing ensures product safety and efficacy.

Conclusions:

  • Rigorous safety testing is paramount for biological products derived from novel biotechnologies.
  • Understanding product characteristics and manufacturing is key to risk assessment.
  • A combination of general and specific tests is necessary for regulatory approval.